Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Evaluation of a pediatric continuous-infusion vancomycin therapy guideline.

McKamy S, Chen T, Lee M, Ambrose PJ.

Am J Health Syst Pharm. 2012 Dec 1;69(23):2066-71. doi: 10.2146/ajhp120072.

PMID:
23172265
2.

Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study.

Wysocki M, Delatour F, Faurisson F, Rauss A, Pean Y, Misset B, Thomas F, Timsit JF, Similowski T, Mentec H, Mier L, Dreyfuss D.

Antimicrob Agents Chemother. 2001 Sep;45(9):2460-7.

3.

Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.

Eiland LS, English TM, Eiland EH 3rd.

Ann Pharmacother. 2011 May;45(5):582-9. doi: 10.1345/aph.1P588. Epub 2011 Apr 26.

PMID:
21521865
4.

An evaluation of vancomycin dosing for complicated infections in pediatric patients.

Durham SH, Simmons ML, Mulherin DW, Foland JA.

Hosp Pediatr. 2015 May;5(5):276-81. doi: 10.1542/hpeds.2014-0081.

5.

Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.

Kullar R, Leonard SN, Davis SL, Delgado G Jr, Pogue JM, Wahby KA, Falcione B, Rybak MJ.

Pharmacotherapy. 2011 May;31(5):441-8. doi: 10.1592/phco.31.5.441.

PMID:
21923425
6.

Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.

Cano EL, Haque NZ, Welch VL, Cely CM, Peyrani P, Scerpella EG, Ford KD, Zervos MJ, Ramirez JA, Kett DH; Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Study Group.

Clin Ther. 2012 Jan;34(1):149-57. doi: 10.1016/j.clinthera.2011.12.013.

PMID:
22284995
7.
8.

High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion.

Vuagnat A, Stern R, Lotthe A, Schuhmacher H, Duong M, Hoffmeyer P, Bernard L.

J Clin Pharm Ther. 2004 Aug;29(4):351-7.

PMID:
15271102
9.

Continuous infusion vancomycin for treatment of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients.

Fung L.

Ann Pharmacother. 2012 Oct;46(10):e26. doi: 10.1345/aph.1R272. Epub 2012 Oct 2.

PMID:
23032658
10.

Improved vancomycin dosing in children using area under the curve exposure.

Le J, Bradley JS, Murray W, Romanowski GL, Tran TT, Nguyen N, Cho S, Natale S, Bui I, Tran TM, Capparelli EV.

Pediatr Infect Dis J. 2013 Apr;32(4):e155-63. doi: 10.1097/INF.0b013e318286378e.

11.

The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.

Waineo MF, Kuhn TC, Brown DL.

J Clin Pharm Ther. 2015 Jun;40(3):259-65. doi: 10.1111/jcpt.12270. Epub 2015 Apr 11. Review.

PMID:
25865426
12.

Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.

Ringenberg T, Robinson C, Meyers R, Degnan L, Shah P, Siu A, Sturgill M.

Pediatr Infect Dis J. 2015 Jul;34(7):742-7. doi: 10.1097/INF.0000000000000664.

PMID:
25629890
13.

Vancomycin serum concentration during febrile neutropenia in patients with acute myeloid leukemia.

Hochart C, Berthon C, Corm S, Gay J, Cliquennois M, Tricot S, Alfandari S.

Med Mal Infect. 2011 Dec;41(12):652-6. doi: 10.1016/j.medmal.2011.09.014. Epub 2011 Nov 6.

PMID:
22056376
14.

Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.

Inparajah M, Wong C, Sibbald C, Boodhan S, Atenafu EG, Naqvi A, Dupuis LL.

Pharmacotherapy. 2010 Jan;30(1):43-51. doi: 10.1592/phco.30.1.43.

PMID:
20030472
15.

Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy.

Akers KS, Cota JM, Chung KK, Renz EM, Mende K, Murray CK.

J Burn Care Res. 2012 Nov-Dec;33(6):e254-62. doi: 10.1097/BCR.0b013e31825042fa.

PMID:
22878490
16.

Performance of a vancomycin dosage regimen developed for obese patients.

Reynolds DC, Waite LH, Alexander DP, DeRyke CA.

Am J Health Syst Pharm. 2012 Jun 1;69(11):944-50. doi: 10.2146/ajhp110324.

PMID:
22610026
17.

A prospective study of vancomycin pharmacokinetics and dosage requirements in pediatric cancer patients.

Chang D, Liem L, Malogolowkin M.

Pediatr Infect Dis J. 1994 Nov;13(11):969-74.

PMID:
7845750
18.

Vancomycin intermittent dosing versus continuous infusion for treatment of ventilator-associated pneumonia in trauma patients.

Schmelzer TM, Christmas AB, Norton HJ, Heniford BT, Sing RF.

Am Surg. 2013 Nov;79(11):1185-90.

PMID:
24165255
19.

Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.

Asbury WH, Darsey EH, Rose WB, Murphy JE, Buffington DE, Capers CC.

Ann Pharmacother. 1993 Apr;27(4):490-6.

PMID:
8477127
20.

Neonatal vancomycin continuous infusion: still a confusion?

Gwee A, Cranswick N, Metz D, Coghlan B, Daley AJ, Bryant PA, Curtis N.

Pediatr Infect Dis J. 2014 Jun;33(6):600-5. doi: 10.1097/INF.0000000000000243. Review.

PMID:
24378952
Items per page

Supplemental Content

Write to the Help Desk